Menu
GeneBe

rs761591158

Variant summary

Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting

The NM_020433.5(JPH2):c.692G>A(p.Arg231Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000475 in 1,530,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00038 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00049 ( 0 hom. )

Consequence

JPH2
NM_020433.5 missense

Scores

1
6
12

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 2.57
Variant links:
Genes affected
JPH2 (HGNC:14202): (junctophilin 2) Junctional complexes between the plasma membrane and endoplasmic/sarcoplasmic reticulum are a common feature of all excitable cell types and mediate cross talk between cell surface and intracellular ion channels. The protein encoded by this gene is a component of junctional complexes and is composed of a C-terminal hydrophobic segment spanning the endoplasmic/sarcoplasmic reticulum membrane and a remaining cytoplasmic domain that shows specific affinity for the plasma membrane. This gene is a member of the junctophilin gene family. Alternative splicing has been observed at this locus and two variants encoding distinct isoforms are described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.20013422).
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000375 (57/151832) while in subpopulation AMR AF= 0.000722 (11/15240). AF 95% confidence interval is 0.00047. There are 0 homozygotes in gnomad4. There are 30 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
JPH2NM_020433.5 linkuse as main transcriptc.692G>A p.Arg231Gln missense_variant 2/6 ENST00000372980.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
JPH2ENST00000372980.4 linkuse as main transcriptc.692G>A p.Arg231Gln missense_variant 2/65 NM_020433.5 P1Q9BR39-1

Frequencies

GnomAD3 genomes
AF:
0.000375
AC:
57
AN:
151832
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000725
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000722
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000619
Gnomad OTH
AF:
0.000480
GnomAD3 exomes
AF:
0.000241
AC:
31
AN:
128486
Hom.:
0
AF XY:
0.000214
AC XY:
15
AN XY:
70138
show subpopulations
Gnomad AFR exome
AF:
0.000160
Gnomad AMR exome
AF:
0.000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000479
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000486
AC:
670
AN:
1378216
Hom.:
0
Cov.:
32
AF XY:
0.000468
AC XY:
318
AN XY:
679460
show subpopulations
Gnomad4 AFR exome
AF:
0.0000958
Gnomad4 AMR exome
AF:
0.000198
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000127
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000586
Gnomad4 OTH exome
AF:
0.000504
GnomAD4 genome
AF:
0.000375
AC:
57
AN:
151832
Hom.:
0
Cov.:
32
AF XY:
0.000405
AC XY:
30
AN XY:
74152
show subpopulations
Gnomad4 AFR
AF:
0.0000725
Gnomad4 AMR
AF:
0.000722
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000619
Gnomad4 OTH
AF:
0.000480
Alfa
AF:
0.000323
Hom.:
0
Bravo
AF:
0.000385
ExAC
AF:
0.0000956
AC:
6

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hypertrophic cardiomyopathy 17;C5561970:Cardiomyopathy, dilated, 2E Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsSep 21, 2021- -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxApr 14, 2023Reported in an individual with DCM, who also harbored a missense variant in the HCN4 gene, and in an individual with RCM (Arbustini et al., 2017; van Lint et al., 2019); Also reported in an abstract as a de novo occurrence in a proband undergoing whole exome sequencing (Tang et al., 2013); however, a pathogenic splice site variant in the MYBPC3 gene was also identified, which was inherited from an affected parent; In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 28254189, 30235249, 25356970, 30847666, 35001666, 28771489) -
Hypertrophic cardiomyopathy 17 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingVictorian Clinical Genetics Services, Murdoch Childrens Research InstituteFeb 02, 2022Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as VUS-3B. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with hypertrophic cardiomyopathy 17 (MIM# 613873). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to glutamine. (I) 0251 - This variant is heterozygous. (I) 0302 - Variant is present in gnomAD (v3) <0.001 for a dominant condition (57 heterozygotes, 0 homozygotes). (SP) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0808 - Previous reports of pathogenicity for this variant are conflicting. This variant has been classified as either likely benign or a VUS in the literature and by multiple clinical diagnostic laboratories, and has been identified in individuals with either dilated cardiomyopathy, hypertrophic cardiomyopathy or restrictive cardiomyopathy (ClinVar; PMIDs: 28771489, 28254189, 30847666). (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Hypertrophic cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeJan 15, 2024This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 231 of the JPH2 protein (p.Arg231Gln). This variant is present in population databases (rs761591158, gnomAD 0.05%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with JPH2-related conditions (PMID: 28254189, 28771489, 30847666). ClinVar contains an entry for this variant (Variation ID: 225099). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 26, 2023The p.R231Q variant (also known as c.692G>A), located in coding exon 2 of the JPH2 gene, results from a G to A substitution at nucleotide position 692. The arginine at codon 231 is replaced by glutamine, an amino acid with highly similar properties. This alteration has been reported in cardiomyopathy genetic testing cohorts; however, clinical details were limited (Mademont-Soler I et al. PLoS One, 2017 Aug;12:e0181465; van Lint FHM et al. Neth Heart J, 2019 Jun;27:304-309). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.40
Cadd
Benign
21
Dann
Uncertain
1.0
DEOGEN2
Benign
0.22
T
Eigen
Benign
0.045
Eigen_PC
Benign
-0.0057
FATHMM_MKL
Benign
0.19
N
LIST_S2
Uncertain
0.96
D
M_CAP
Uncertain
0.29
D
MetaRNN
Benign
0.20
T
MetaSVM
Benign
-0.87
T
MutationAssessor
Uncertain
2.4
M
MutationTaster
Benign
0.63
N
PrimateAI
Pathogenic
0.89
D
PROVEAN
Uncertain
-2.4
N
REVEL
Benign
0.18
Sift
Benign
0.071
T
Sift4G
Uncertain
0.040
D
Polyphen
0.97
D
Vest4
0.16
MVP
0.84
ClinPred
0.43
T
GERP RS
3.0
Varity_R
0.15
gMVP
0.51

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs761591158; hg19: chr20-42788735; COSMIC: COSV65904533; API